FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15548111000001108: Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1569541000001115 Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1569551000001117 Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Is a Trabectedin 250microgram powder for solution for infusion vials true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has active ingredient Trabectedin true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has specific active ingredient Trabectedin true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Is a Yondelis true Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) 1 vial Has AMP True Yondelis 0.25mg powder for concentrate for solution for infusion vials (Immedica Pharma AB) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start